QTI
QT Imaging Holdings, Inc.
NASDAQ · Healthcare · Medical - Devices · US
$2.64
−4.00%Income statement
| Metric | TTM | 2025 | 2024 | 2023 | 2022 |
|---|---|---|---|---|---|
| Revenue | |||||
| Total Revenue | 28.2M | 18.9M | 4.9M | 40.4K | — |
| Cost of Revenue | 17.0M | 10.3M | 2.2M | 135.0K | — |
| Gross Profit | 11.1M | 8.6M | 2.6M | (94.6K) | — |
| Operating Expenses | |||||
| R&D Expense | 5.1M | 3.9M | 3.3M | 1.5M | — |
| SG&A Expense | 11.0M | 9.1M | 11.5M | 3.4M | 4.3M |
| General & Admin Expense | — | — | — | 4.9M | — |
| Selling & Marketing Expense | — | — | — | (1.5M) | — |
| Other Expenses | — | — | — | — | — |
| Total Operating Expenses | 16.1M | 13.0M | 14.8M | 4.9M | 4.3M |
| Cost and Expenses | 33.1M | 23.4M | 17.1M | 5.0M | 4.3M |
| Operating Income (EBIT) | (4.9M) | (4.4M) | (12.2M) | (5.0M) | (4.3M) |
| Non-Operating | |||||
| Interest Income | — | — | — | 1.5M | 1.6M |
| Interest Expense | 3.3M | 2.6M | 4.5M | 544.8K | 23.1K |
| Net Interest Income | (3.3M) | (2.6M) | (4.5M) | 982.0K | 1.6M |
| Other Non-Op Income/Expense | (13.5M) | (16.6M) | 3.2M | (1.1M) | 2.0M |
| Non-Operating Income (excl Interest) | 10.2M | 14.0M | (7.7M) | 544.6K | — |
| EBT (Pre-Tax Income) | (18.4M) | (21.1M) | (9.0M) | (6.1M) | (2.3M) |
| Income Tax Expense | (5.8K) | (1.0K) | (15.8K) | 1.6K | 486.6K |
| Bottom Line | |||||
| Net Income | (18.4M) | (21.1M) | (9.0M) | (6.1M) | (2.8M) |
| Earnings from Cont. Ops | (18.4M) | (21.1M) | (9.0M) | (6.1M) | (2.8M) |
| Earnings from Discont. Ops | — | — | — | — | — |
| Bottom Line Net Income | (18.4M) | (21.1M) | (14.2M) | (6.1M) | (3.9M) |
| Per Share | |||||
| Basic EPS | ($1.17) | ($2.01) | ($0.71) | ($0.54) | ($0.41) |
| Diluted EPS | ($1.17) | ($2.01) | ($0.71) | ($0.54) | ($0.41) |
| Revenue Per Share | $1.90 | $1.81 | $0.24 | $0.00 | $0.00 |
| Shares | |||||
| Basic Shares Outstanding | 14.8M | 10.5M | 20.0M | 9.6M | 9.5M |
| Diluted Shares Outstanding | 14.8M | 10.5M | 20.0M | 9.6M | 9.5M |
| Profitability Metrics | |||||
| EBITDA | (15.0M) | (18.3M) | (4.3M) | (5.1M) | (4.3M) |
| D&A | 55.1K | 131.0K | 230.8K | 480.7K | — |
| EBIT | (15.1M) | (18.4M) | (4.5M) | (5.6M) | (4.3M) |
As reported, in the filing currency · TTM sums the four latest quarters; MRQ is the latest quarter · Negatives in parentheses; a dash is a line the filing does not carry · Data as of Jun 1, 2026